Dr. Reddy’s Gets Abatacept Biosimilar Approval
The Story: Dr. Reddy’s has received CDSCO approval for its abatacept biosimilar in India for rheumatoid arthritis and psoriatic arthritis.
The Take: The approval gives Dr. Reddy’s an opportunity to compete with Orencia, while strengthening its biologics portfolio in India.
SkyDrive, Air India and Suzuki Explore eVTOL Medical Routes
The Story: SkyDrive, Air India and Suzuki will evaluate eVTOL routes in India for medical logistics, including radioactive isotopes and emergency organ transport.
The Take: The initiative could cut critical transport times in congested cities and open an early commercial use case for eVTOLs in India.
GC Biopharma Expands Hunter Syndrome Treatment Access
The Story: GC Biopharma has secured CDSCO and Taiwan approvals for Hunterase IV, expanding access to its Hunter syndrome treatment across key Asian markets.
The Take: The approvals strengthen GC Biopharma’s rare disease portfolio and expand Hunterase IV’s reach to 14 countries.
